Ligand Pharmaceuticals

Summary

In 1987 was created Ligand Pharmaceuticals, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the San Diego.

The typical case for the fund is to invest in rounds with 1 participant. Despite the Ligand Pharmaceuticals, startups are often financed by BioAdvance, 13 Ventures.

This Ligand Pharmaceuticals works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 47 percentage points more often commits exit comparing to other companies. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top amount of exits for fund were in 2015. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Medical, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Palvella Therapeutics, Viking Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups.